These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17416103)

  • 21. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau and axonopathy in neurodegenerative disorders.
    Higuchi M; Lee VM; Trojanowski JQ
    Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport.
    Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE
    J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma tau/amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease.
    Park JC; Han SH; Yi D; Byun MS; Lee JH; Jang S; Ko K; Jeon SY; Lee YS; Kim YK; Lee DY; Mook-Jung I
    Brain; 2019 Mar; 142(3):771-786. PubMed ID: 30668647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of tau in Alzheimer's disease.
    Trojanowski JQ; Lee VM
    Med Clin North Am; 2002 May; 86(3):615-27. PubMed ID: 12168561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Going new places using an old MAP: tau, microtubules and human neurodegenerative disease.
    Garcia ML; Cleveland DW
    Curr Opin Cell Biol; 2001 Feb; 13(1):41-8. PubMed ID: 11163132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau protein mutations confirmed as neuron killers.
    Vogel G
    Science; 1998 Jun; 280(5369):1524-5. PubMed ID: 9644015
    [No Abstract]   [Full Text] [Related]  

  • 32. Functions and malfunctions of the tau proteins.
    Shahani N; Brandt R
    Cell Mol Life Sci; 2002 Oct; 59(10):1668-80. PubMed ID: 12475178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
    Brandt R; Hundelt M; Shahani N
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.
    Ubhi K; Rockenstein E; Doppler E; Mante M; Adame A; Patrick C; Trejo M; Crews L; Paulino A; Moessler H; Masliah E
    Acta Neuropathol; 2009 Jun; 117(6):699-712. PubMed ID: 19252918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau function and dysfunction in neurons: its role in neurodegenerative disorders.
    Avila J; Lim F; Moreno F; Belmonte C; Cuello AC
    Mol Neurobiol; 2002 Jun; 25(3):213-31. PubMed ID: 12109872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tauons and prions: infamous cousins?
    Novak P; Prcina M; Kontsekova E
    J Alzheimers Dis; 2011; 26(3):413-30. PubMed ID: 21694453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.